☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Supply Agreement
Merck Signs a Supply Agreement with Werewolf for WTX-124 INDUKINE Program to Treat Solid Tumors
August 19, 2021
BeiGene Signs a Supply Agreement with PureTech for LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors
July 8, 2021
Merck Collaborates with OncoSec to Evaluate TAVO (tavokinogene telseplasmid) + Keytruda (pembrolizumab) in P-III KEYNOTE-C87 Trial...
July 7, 2021
Merck Signs ~$1.2B Supply Agreement with US Government for Molnupiravir to Treat COVID-19
June 10, 2021
Prestige Biopharma and Pharmapark Sign an Exclusive License and Supply Agreement to Commercialize HD204 (biosimilar- bevacizumab)...
April 16, 2021
PhaseBio Signs a Supply Agreement with BioVectra to Support the Development and Commercialization of Bentracimab
March 12, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.